121 |
Coated vs Non-Coated Wires for CTO |
James R. Margolis |
Jul. 08. 05 |
120 |
Long Term Outcome of 1,000 CTO Cases |
Toshiya Muramatsu |
Jul. 08. 05 |
119 |
Zen Philosophy - The KEY to CTO Success |
Gregg W. Stone |
Jul. 08. 05 |
118 |
Lesson Learnt in the Complication Session at EuroPCR 2004 |
Eric Eeckhout |
Jul. 01. 05 |
117 |
Clinical Relevance of Stent Fractures in the Treatment of SFA Lesion |
Giancarlo Biamino |
Jul. 01. 05 |
116 |
Lesson Learnt During Live Cases Transmission at EuroPCR 2004 |
Jean Fajadet |
Jul. 01. 05 |
115 |
Drug-eluting Stents,Late Loss,and Restenosis DES to Prevents MIs |
Richard E. Kuntz |
Jul. 01. 05 |
114 |
What Are The Proper End Points for DES Trial |
Alan C. Yeung |
Jul. 01. 05 |
113 |
Evidence-Based Medicine Analysis of Current DES Clinical |
Gregg W. Stone |
Jul. 01. 05 |
112 |
Pathology of Vulnerable Plaque |
Renu Virmani |
Jun. 16. 05 |